药品制造商补充说，EMS杂质在药物生产过程中产生，通常认为是甲磺酸奈非那韦。
The drugmaker added that the EMS impurities were caused by the manufacturing process of the drug, which is known generically as nelfinavir mesylate.
在治疗过程中利托那韦可作其他蛋白酶抑制剂的增效剂。
In the course of treatment, Ritonavir can be used for other protease inhibitors synergist.
应用推荐